Medical devices, healthcare technology and the business of care
510(k) clearance · K260523

QGuideCT (1.0)

Medis Medical Imaging Systems BV · Decision date Oct 5, 2026

MEDTECHLEDGER EXPLANATIONK260523

What did the FDA decide?

Medis Medical Imaging Systems BV, based in Leiden, Netherlands, received a substantially equivalent (SESE) decision for QGuideCT (1.0) under 510(k) number K260523. FDA recorded the decision on 2026-10-05, with the application received 02/17/2026. The device falls under regulation 892.2050, classified as Automated Radiological Image Processing Software, with primary product code QIH and subsequent product code LLZ; the review panel and medical specialty are both Radiology. This is a 510(k) clearance, not a PMA approval.

The record identifies the submission as a Traditional 510(k), not reviewed by a third party, not a combination product, and without an authorized Predetermined Change Control Plan. The public page shows a statement field but no statement text in the available excerpts. The excerpts do not describe the device's specific components, intended clinical use, or the evidence supporting the equivalence determination; those details would need to come from the underlying FDA documents rather than this summary page.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Oct 5, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260523
Regulatory pathway
510(k) premarket notification
Product code
QIH
Decision code
SESE
Decision date
Oct 5, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Automated Radiological Image Processing Software.

Product code
QIH
FDA device class
2

FDA decision timeline

  1. K260523 received

    Application receipt date recorded by FDA.

  2. K260523 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code QIH

Product / regulatory recordCompanyPathwayDecision dateSource
Clever OneK260372
Ewoosoft Co., Ltd.510(k) clearanceNov 4, 2026FDA
Peek Health, S.A.510(k) clearanceNov 4, 2026FDA
AVICENNA.AI510(k) clearanceOct 19, 2026FDA
UAB Ligence510(k) clearanceOct 7, 2026FDA
NeuroDRK262134
Deep Reasoning Ai, Inc.510(k) clearanceOct 7, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medis Medical Imaging Systems BV

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Leiden

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records